| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/GIM.2012.18 |
| P8608 | Fatcat ID | release_xj42tb5c45enzjypcbdqvz6rmi |
| P932 | PMC publication ID | 3396560 |
| P698 | PubMed publication ID | 22402756 |
| P5875 | ResearchGate publication ID | 221688698 |
| P50 | author | Albert de la Chapelle | Q5618748 |
| Ewout W. Steyerberg | Q37828851 | ||
| Floor Backes | Q38643301 | ||
| David E. Cohn | Q39381089 | ||
| Mark Jenkins | Q42412309 | ||
| John Hopper | Q56726496 | ||
| Subha Madhavan | Q106814502 | ||
| Noralane Lindor | Q110912119 | ||
| P2093 | author name string | Elena Stoffel | |
| Sapna Syngal | |||
| Fay Kastrinos | |||
| Heather Hampel | |||
| Colon Cancer Family Registry | |||
| Graham Casey | |||
| Robert Haile | |||
| Rowena C Mercado | |||
| Judith Balmana | |||
| P2860 | cites work | Endometrial cancer and Lynch syndrome: clinical and pathologic considerations | Q28303873 |
| The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history | Q30501708 | ||
| BayesMendel: an R environment for Mendelian risk prediction | Q33241509 | ||
| Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. | Q33738168 | ||
| Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. | Q34732921 | ||
| Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma. | Q34994571 | ||
| Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch Syndrome | Q35084724 | ||
| The accuracy of diagnoses as reported in families with cancer: a retrospective study. | Q35432185 | ||
| Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history | Q35895179 | ||
| Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications | Q36396727 | ||
| Prediction of germline mutations and cancer risk in the Lynch syndrome | Q36882484 | ||
| Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients | Q36890349 | ||
| Testing women with endometrial cancer to detect Lynch syndrome | Q36920374 | ||
| Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening | Q37066133 | ||
| Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients | Q37098318 | ||
| Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome | Q37103142 | ||
| Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer | Q43298916 | ||
| Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer | Q43722882 | ||
| Prediction of Lynch syndrome in consecutive patients with colorectal cancer | Q43786046 | ||
| Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients | Q44152876 | ||
| A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers | Q45120833 | ||
| Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger | Q46524243 | ||
| Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer | Q53226230 | ||
| Mutation prediction models in Lynch syndrome: evaluation in a clinical genetic setting | Q57259905 | ||
| Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients | Q57259926 | ||
| Prediction of MLH1 and MSH2 Mutations in Lynch Syndrome | Q57260018 | ||
| Prospective Determination of Prevalence of Lynch Syndrome in Young Women With Endometrial Cancer | Q60167347 | ||
| Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors | Q77639637 | ||
| Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients | Q80050907 | ||
| Are prediction models for Lynch syndrome valid for probands with endometrial cancer? | Q84316559 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Lynch syndrome | Q783644 |
| endometrial cancer | Q944777 | ||
| P304 | page(s) | 670-680 | |
| P577 | publication date | 2012-03-08 | |
| P1433 | published in | Genetics in Medicine | Q15765508 |
| P1476 | title | Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases | |
| P478 | volume | 14 |
| Q49905350 | A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settings |
| Q38798530 | Advances in Hereditary Colorectal and Pancreatic Cancers |
| Q30361978 | Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study |
| Q93011987 | Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting |
| Q48952576 | Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age. |
| Q38129858 | Criteria and prediction models for mismatch repair gene mutations: a review. |
| Q39045081 | Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas |
| Q38794258 | Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome |
| Q33874719 | Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer |
| Q31139897 | Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relatives |
| Q52633302 | Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome. |
| Q28085485 | Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment? |
| Q35235483 | Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing |
| Q38848447 | Laboratory Assays in Evaluation of Lynch Syndrome in Patients with Endometrial Carcinoma |
| Q38073703 | Management of Genetic Syndromes Predisposing to Gynecologic Cancers |
| Q51023349 | Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer. |
| Q37038863 | Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas |
| Q33817058 | Role of the clinical pathology laboratory in the evaluation of endometrial carcinomas for Lynch syndrome |
| Q102062996 | Testing for lynch syndrome in people with endometrial cancer using immunohistochemistry and microsatellite instability-based testing strategies - A systematic review of test accuracy |
| Q63966105 | The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome |
| Q38609057 | UK colorectal cancer patients are inadequately assessed for Lynch syndrome. |
| Q37492615 | Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer |
Search more.